Agreed, Lantheus do have a sub par product RE prostate cancer therapy. They have been lucky to be first mover RE imaging however once TLX591 hits the market, their demise will be obvious.
IMO
- Forums
- ASX - By Stock
- TLX
- Rad in trading halting - Lantheus investing in
Rad in trading halting - Lantheus investing in, page-3
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$19.19 |
Change
0.780(4.24%) |
Mkt cap ! $6.421B |
Open | High | Low | Value | Volume |
$18.85 | $19.19 | $18.78 | $22.02M | 1.155M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2216 | $19.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.20 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2216 | 19.180 |
1 | 1 | 19.090 |
3 | 5161 | 19.060 |
1 | 10000 | 19.050 |
3 | 42946 | 19.040 |
Price($) | Vol. | No. |
---|---|---|
19.200 | 1000 | 1 |
19.210 | 1000 | 1 |
19.230 | 1060 | 1 |
19.240 | 1100 | 2 |
19.250 | 5000 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |